Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability

Journal of Pathology

Volumn 179, Issue 4, 1996, Pages 370-375

  Ilyas, M ^a   Tomlinson, I P M ^b   Novelli, M R ^b   Hanby, A ^c   Bodmer, W F ^b   Talbot, I C ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

Author keywords

Colorectal carcinoma (CRC); p53; Replication error (RER)

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA REPLICATION; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; COLORECTAL NEOPLASMS; DNA REPLICATION; DNA, NEOPLASM; HUMANS; IMMUNOENZYME TECHNIQUES; MICROSATELLITE REPEATS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029842358     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199608)179:4<370::AID-PATH627>3.0.CO;2-N     Document Type: Article

References (42)

1. Foulds L. The natural history of cancer. J Chronic Dis 1958; 8: 2-37.
2. Land H, Parada LF, Weinberg RA. Cellular oncogenes and multistep carcinogenesis. Science 1983; 222: 771-778.
3. Weinberg RA. Oncognenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49: 3713-3721.
4. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
5. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270.
6. Peltomaki P. Microsatellite instability and hereditary non-polyposis colon cancer. J Pathol 1995; 176: 329-330.
7. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816.
8. Aaltonen LA, Peltomaki P. Genes involved in hereditary nonpolyposis colorectal carcinoma. Anticancer Res 1994; 14: 1657-1660.
9. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819.
10. Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994; 14: 1631-1634.
11. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLHI is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258-261.
12. Fishel R, Lescoe MK, Rao MR. et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-1038.
13. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215-1225.
14. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80.
15. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993; 75: 1227-1236.
16. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994; 54: 5059-5073.
17. Eshleman JR, Lang EZ, Bowerfind GK, et al. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene 1995; 10: 33-37.
18. de Wind N, Dekker NM, Berns A, Radman M, te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair, methylation tolerance, hyperrecombination and predisposition to cancer. Cell 1995; 82: 321-330.
19. Cleaver JE. It was a very good year for DNA repair. Cell 1994; 76: 1-4.
20. Modrich P. Mismatch repair, genetic stability, and cancer. Science 1994; 266: 1959-1960.
21. Kunkel TA. Nucleotide repeats. Slippery DNA and diseases. Nature 1993; 365: 207-208.
22. Fishel R, Ewel A, Lee S, Lescoe MK, Griffith J. Binding of mismatched microsatellite DNA sequences by the human MSH2 protein. Science 1994; 266: 1403-1405.
23. Fishel R, Kolodner RD. Identification of mismatch repair genes and their role in the development of cancer. Curr Opin Genet Dev 1995; 5: 382-395.
24. Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 1995; 9: 48-55.
25. Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358: 15-16.
26. el-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54: 1169-1174.
27. Blaydes JP, Schlumberger M, Wynford-Thomas D, Wyllie FS. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation. Oncogene 1995; 10: 307-317.
28. Donehower LA, Bradley A. The tumor suppressor p53. Biochim Biophys Acta 1993; 1155: 181-205.
29. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878.
30. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148-156.
31. Gyapay G, Morissette J, Vignal A, et al. The 1993-94 genethon human genetic-linkage map. Nature Genet 1994; 7: 246-339.
32. Warnich L, Groenewald I, Theart L, Relief AE. Highly informative dinucleotide repeat polymorphism at the D11S29 locus on chromosome 11q23. Hum Genet 1992; 89: 357-359.
33. Telatar M, Concannon P, Tolun A. Dionucleotide repeat polymorphism at the ncam locus. Hum Mol Genet 1994; 842-843.
34. Hauge XY, Grandy DK, Eubanks JH, Evans GA, Civelli O, Litt M. Detection and characterization of additional DNA polymorphisms in the dopamine-d2 receptor gene. Genomics 1991; 527-530.
35. Costa A, Marasca R, Valentinis B, et al. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J Pathol 1995; 176: 45-53.
36. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J Pathol 1994; 172: 1-4.
37. Shaulian E, Zauberman A, Ginsberg D, Oren M. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol 1992; 12: 5581-5592.
38. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987; 1: 1303-1306.
39. Jass JR. Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer. Histopathology 1995; 27: 263-267.
40. Jass JR, Stewart SM, Stewart J, Lane MR. Hereditary non-polyposis colon cancer - morphologies, genes and mutations. Mutat Res 1994; 310: 125-133.
41. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172: 5-12.
42. Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849-5852.